TECENTRIQ (atezolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** ATEZOLIZUMAB

**Strength:** 840 mg/14mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761034)

**Pharmacologic class:** Antibodies [CS], Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]